Scientists raise concern over hydroxychloroquine study


Hydroxychloroquine is often used to treat arthritis
Hydroxychloroquine is often used to treat arthritis

Dozens of scientists have raised concerns over a large-scale study of hydroxychloroquine and chloroquine published in the Lancet that led to the World Health Organization suspending clinical trials of the anti-viral drugs as a potential treatment for COVID-19.

Hydroxychloroquine, normally used to treat arthritis, has become one of the most high profile drugs being tested for use against the new coronavirus partly because of endorsements by public figures including US President Donald Trump.

Researchers on Friday stood by the conclusion of their study that treatment with hydroxychloroquine and chloroquine, an anti-malarial, showed no benefit and even increased the likelihood of patients dying in hospital.

The observational research, led by Mandeep Mehra of the Brigham and Women’s Hospital in the US, looked at records from 96,000 patients in hundreds of hospitals between December and April and compared those who received treatment with a control group.

The research, published in the Lancet on May 22, followed numerous smaller studies that suggested hydroxychloroquine is ineffective in treating COVID-19 and might even be more dangerous than doing nothing.

Both drugs can produce potentially , particularly heart arrhythmia.

Within days the WHO temporarily suspended use of the drugs in its Solidarity Trial, which has seen hundreds of hospitals across several countries enrol patients to test possible treatments for COVID-19.

“This impact has led many researchers around the world to scrutinise in detail the publication in question,” said the in response to the study, which was signed by a number of prominent scientists and published Thursday.

It added that this scrutiny raised “both methodological and data integrity concerns”.

One of the main concerns was a lack of information about the countries and hospitals that contributed data, which was provided by Chicago-based healthcare data analytics firm Surgisphere.

Other issues highlighted included discrepancies in the data for Australia, where they said there were more deaths recorded in the hospitals covered by the study than official figures for the entire country.

In a statement late Friday the Lancet said it was publishing a correction to amend the discrepancy, which occurred because one hospital had self-designated as being in the Australasia continent, when it should have been in Asia.

The Lancet encourages scientific debate and will publish responses to the study, along with a response from the authors, in the journal in due course,” it said, adding that the conclusion of the study remained unchanged.

‘Serious doubts’

Mehra also released a statement saying the authors of the study had initiated an academic review of their work, adding that it had been undertaken “in the absence of a large, robust and publicly available dataset on hydroxychloroquine or chloroquine”.

“As articulated in the study, the authors have underscored the importance and value of randomized, clinical trials and articulated that such trials will be necessary before any conclusions can be reached,” he said.

“However, results are not anticipated from such trials until the summer and, given the urgency of the situation, leveraging the available dataset was an intermediary step.”

A spokesman for the WHO said a comprehensive review of the drugs was expected to reach a conclusion in mid-June.

Among the signatories of the letter questioning the research were clinicians, epidemiologists and other researchers from around the world, from Harvard to Imperial College London.

Francois Balloux of University College London, said he believed it was his “duty” to add his name to calls for answers to questions about the study and for greater transparency.

“I have serious doubts about the benefit of CQ/HCQ treatment for #COVID19 infection, and cannot wait for the whole drama to be over,” he said on Twitter.

“Though, I believe ‘research integrity’ cannot be invoked only when a paper doesn’t support our preconceptions.”

The letter was also signed by French researcher Philippe Parola, a colleague of the Marseille-based professor Didier Raoult, whose work has been at the forefront of promoting hydroxychloroquine and has also been subject to criticisms over methodology.

The coronavirus crisis has put enormous strain on the normally sedate system of scientific publication, with an avalanche of research and the process of peer review considerably accelerated.

Hydroxychloroquine shows no virus benefit, raises death risk: study

© 2020 AFP

Scientists raise concern over hydroxychloroquine study (2020, May 29)
retrieved 30 May 2020

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.

(Visited 1 times, 1 visits today)

Related posts:

Study paves way for earlier autism diagnosis in Indiana
Critics say choice of Castex as new PM reveals a Macron power grab
Darmbakterien verbessern Prognose von Typ-2-Diabetes
France's new Prime Minister Jean Castex unveils reshuffled cabinet
Kids are lagging and COVID-19 is harming care
Patientenverband kritisiert IQWiG-Bericht zur Prostata-Fusionsbiopsie
Climate change blamed for surge in India's deadly lightning strikes
Coronavirus has forced doctors, insurers to embrace telemedicine like never before
Hong Kong govt orders schools to remove books breaching new security law
DGU-Präsident: „Wir müssen das Reha-Loch für unsere Patienten schließen“
Complications from COVID-19 may depend on von Willebrand factor in the blood
Bei chronischer GERD nicht routinemäßig auf ein EAC screenen
Trial wraps up for French drugmaker in deadly diet-pill scandal
Sewage can help track pandemic virus trends
Lockdown in Colombia leads to spike in domestic violence
ESHRE 2020: Krebstherapie muss für junge Frauen nicht das ende der Fertilität bedeuten
Victoria is undeniably in a second wave of COVID-19, and it's time to plan for another statewide loc...
Former French intelligence agents go on trial accused of spying for China
Bayerisches Krebsforschungszentrum startet Bürgertelefon - Biermann Medizin
Live Coronavirus Updates: Federal Workers in the U.S. Return to Offices
Czech volunteers develop functioning lung ventilator in days
Durchbrechen der Schwelle von Corona-Neuinfektionen: Dynamik ist entscheidend
China's Inner Mongolia region reports bubonic plague case
Ein Protein, das uropathogene Bakterien abfängt
Trump Falsely Claims ‘99 Percent’ of Virus Cases Are ‘Totally Harmless’
When coronavirus robs you of your sense of smell
Paracelsus-Kliniken in Reichenbach und Zwickau: Gastroenterologe Treichel ist neuer Chefarzt
Bubonic Plague Is Diagnosed in China
Cancer treatment in young women need not mean the end of their fertility
Gencode für die Herzreparatur mit Stammzellen mithilfe Künstlicher Intelligenz entschlüsselt
Louvre museum reopens after 16-week shutdown
Fiji reports first coronavirus case in 78 days
Italy’s Ennio Morricone, Oscar-winning composer for the movies, dies at 91
Covid-19 pushes US hospitals to the brink as cases in India soar
Haute couture goes digital as Paris Fashion Week clicks off online
Erbgut des Herpes-simplex-Virus 1 entschlüsselt
Brexit talks resume in London after tough week in Brussels
France's new Prime Minister Jean Castex to unveil reshuffled cabinet
Australia closes state border for first time in 100 years to stop spread of Covid-19
Desperate search for survivors as dozens feared dead in southwest Japan floods
New guidelines for children and adolescents with type 2 diabetes
Croatia's ruling conservatives win parliamentary vote
UK pays tribute to National Health Service on 72nd birthday
Assessing the Real Coronavirus Death Rate: Live Updates
Kazakhstan imposes 'second wave' of restrictions as coronavirus surges
239 Experts With One Big Claim: The Coronavirus Is Airborne
Fresh Spanish virus outbreak sees 70,000 locked down
Greece shuts border to Serbians after virus spike
India reports record daily cases in coronavirus battle
Formula One drivers all wear ‘End Racism’ T-shirts at season-opening Austrian Grand Prix
South Africa deploys military medics to virus hotspot
Algeria buries repatriated skulls of resistance fighters as it marks independence from France
How Covid-19 contaminated French tourism
Iran reports its highest one-day Covid-19 death toll, topping record set earlier in week
Iran reports new record one-day virus death toll of 163: official
Death toll in Ethiopia surpasses 150 from demonstrations following killing of popular singer
Mexico's COVID deaths pass 30,000, world's 5th highest total
Virus spike in Spain reveals plight of seasonal farm workers
Japan flooding leaves dozens dead and missing
US records 43,742 new virus cases in 24 hours: tracker
S.Africa reports 10,000 new infections in record 24-hour surge
Green, left-wing Michèle Rubirola becomes Marseille’s first woman mayor
Italy could transfer migrants from Ocean Viking rescue ship on Monday
Mexico Covid-19 deaths exceed 30,000, making it fifth-hardest hit country
US marks polarized July 4 as Trump vows to defeat ‘radical left’ protesters
DNA Linked to Covid-19 Was Inherited From Neanderthals, Study Finds
Coronavirus Updates: Trump Hosts July 4 Event at White House
239 Experts With 1 Big Claim: The Coronavirus Is Airborne
Thousands march in Paris for LGBT rights
How Infrared Images Could Be Part of Your Daily Life
EXCLUSIVE: Algerian President Tebboune says opportunity exists for "appeased relations" with France
Why some people don't want to take a COVID-19 test
Beijing lifts most travel restrictions, says city's outbreak contained
Novel method proposed on multiparametric-MRI for rectal cancer diagnosis
Moderate Drinking May Be Good for the Brain
Russia announces virus deaths exceed 10,000
Hong Kong libraries pull books by territory’s pro-democracy activists in wake of China security law
The Pandemic’s Big Mystery: How Deadly Is the Coronavirus?
Mexico reverses some openings as virus cases continue high
Area C, the chunk of the West Bank the Israeli right has long coveted
Dog in Georgia tests positive for virus that causes COVID-19
Pubs open, gyms shut: England's health dilemma
China plans reforms to organ donation rules
Covid 19: Making the poor poorer
Catalonia places 200,000 people under new lockdown following Covid-19 surge
US marks record 57,683 new COVID-19 cases in 24 hours: tracker
As much of US marks a muted Independence Day, Trump encourages big parties
WHO says first alerted to virus by its office, not China
Paris's Louvre reopens on Monday after lockdown losses of 'over €40 million'
How coronavirus self-isolation fatigue may lead to more beach drownings this summer
what's the new coronavirus saliva test, and how does it work?
The WHO's risky communication strategy created confusion around COVID-19
England's pubs, restaurants and hairdressers reopen as COVID-19 lockdown eases
French jihadist sentenced to 30 years for IS group executions in Syria
We looked at the health star rating of 20,000 foods and this is what we found
Trump rallies against anti-racism protesters seeking to 'defame' heroes
The US has bought most of the world's remdesivir. Here's what it means for the rest of us
Antibodies against phosphorylcholine give protection against rheumatic systemic disease
Researchers determine how much oxygen the brain needs
Britain eases virus quarantine as US under siege

Leave a Reply

Your email address will not be published. Required fields are marked *

Next Post

Researchers use brain imaging to demonstrate weaker neural suppression for those with autism

Sat May 30 , 2020
Credit: CC0 Public Domain According to the National Autism Association, people with autism spectrum disorder (ASD) may experience sensory hypersensitivity. A University of Minnesota Medical School researcher recently published an article in Nature Communications that illustrates why that may be true by showing the differences in visual motion perception in […]